A Proactive Approach to Improved Blood Safety
No matter where you are located, increased travel, climate change, evolving pathogens, emerging pandemics and the need to advance health care practices have put global blood safety at the forefront of industry focus.
With all this change, it’s time to take a proactive approach to protecting patients from the potential dangers of donated blood.
The Mirasol PRT system can help you do it by reducing the pathogen load of a broad range of disease-causing viruses, bacteria and parasites.
The system also inactivates residual white blood cells found in blood components, which may help to reduce transfusion reactions in patients.
Powerful, Proven and So Much Potential
The Mirasol PRT system is the only PRT system shown in a human clinical trial to reduce the transfusion-transmitted infection (TTI) of a disease, reducing TTI of malaria by 87 percent.1
The Right Balance for Better Blood
We believe better blood safety should provide the right balance of efficacy and ease-of-use while maintaining the quality of blood components for patients who need them. The Mirasol PRT system is a simple system that has the power to deliver better patient care, reducing the risks associated with the lifesaving gift of blood.
The Mirasol PRT System
You know better than anyone—these are challenging times. The Mirasol PRT system allows you to meet the needs of your business by optimizing the balance of cost, efficacy and safety of your blood products.2,3
SAFE
The Mirasol PRT system is the only PRT system:
Shown to reduce incidence of a transfusion-transmitted disease in humans